NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer.

Adv Sci (Weinh) · 2023 · PMC10646273 · PMID 37818745

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Considering the crosstalk between metabolic dysregulation and immune cell infiltration, we detected and validated PD‐L1 expression in the different groups by immunohistochemistry, and the results showed an increasing trend of PD‐L1 expression within the TME in the U14‐oeFOXP1 group (Figure 8n ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.